Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,701–5,725 of 7,816 matching trials · page 229 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants NCT02769065 TAK-071; Donepezil; TAK-071 Placebo; Donepezil Placebo Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
TERMINATED | 179 | Takeda INDUSTRY |
2019-06-10 |
|
Effect of Exercise Training in Alzheimer's Patients NCT03981159 Physical training Runs in: Italy · 1 site |
NA other |
COMPLETED | 20 | University of Genova OTHER |
2019-06-10 |
|
Rehabilitation of Attention in Patients With MCI and Brain Subcortical Vascular Changes Using the APT-II NCT02033850 Attention Process Training-II Runs in: Italy · 1 site |
NA other |
COMPLETED | 46 | Azienda Ospedaliero-Universitaria Careggi OTHER |
2019-06-06 |
|
FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia NCT03961386 FallsTalk-C; FallsTalk Runs in: United States · 1 site |
NA other |
UNKNOWN | 100 | Brookside Research & Development Company INDUSTRY |
2019-06-06 |
|
Northern Manhattan Caregiver Intervention Project NCT01306695 New York University Caregiver Intervention (NYUCI); Community Healt... Runs in: United States · 1 site |
NA other |
COMPLETED | 139 | Columbia University OTHER |
2019-06-05 |
|
A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD) NCT03720548 LY3372993; Placebo Runs in: United States · 11 sites |
PHASE1 other |
COMPLETED | 36 | Eli Lilly and Company INDUSTRY |
2019-06-05 |
|
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease NCT03363269 ID1201 Runs in: South Korea · 20 sites |
PHASE2 other |
COMPLETED | 116 | IlDong Pharmaceutical Co Ltd INDUSTRY |
2019-06-04 |
|
Behavioral Activation for Dementia Caregivers NCT03552159 Behavioral activation; Psychoeducation |
NA other |
COMPLETED | 96 | The Hong Kong Polytechnic University OTHER |
2019-06-04 |
|
Intensive Instruction on the Use of Aricept NCT01972204 Intensive adherence instruction; Control Runs in: Japan · 1 site |
NA other |
COMPLETED | 125 | Mirai Iryo Research Center, Inc. OTHER |
2019-06-03 |
|
SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. NCT02036645 MEDI1814 for IV injection; MEDI1814 for Subcutaneous Injection; IV ... Runs in: United States · 10 sites |
PHASE1 other |
COMPLETED | 77 | AstraZeneca INDUSTRY |
2019-06-03 |
|
Group CBT for Aggression in Veterans NCT02233517 Cognitive Behavioral Therapy; Present Centered Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 66 | VA Office of Research and Development OTHER_GOV |
2019-05-31 |
|
Exercise Targeting Cognitive Impairment in Parkinson's Disease NCT02267785 Skill-Based Exercise; Aerobic Exercise; Social Contact Runs in: United States · 1 site |
NA other |
UNKNOWN | 25 | University of Southern California OTHER |
2019-05-31 |
|
Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia NCT02506036 Brain HQ Runs in: United States · 1 site |
NA other |
COMPLETED | 6 | Johns Hopkins University OTHER |
2019-05-31 |
|
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease NCT02519036 ISIS 443139 10 mg; ISIS 443139 30 mg; ISIS 443139 60 mg; ISIS 44313... Runs in: Canada; Germany; United Kingdom · 9 sites |
PHASE1|PHASE2 other |
COMPLETED | 46 | Ionis Pharmaceuticals, Inc. INDUSTRY |
2019-05-31 |
|
Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD NCT03306888 Physical Activity Coaching Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 14 | Teachers College, Columbia University OTHER |
2019-05-30 |
|
Application of Amyloid PET in Cerebral Amyloid Angiopathy NCT03542656 amyloid PET Runs in: Taiwan · 1 site |
PHASE3 other |
COMPLETED | 160 | National Taiwan University Hospital OTHER |
2019-05-30 |
|
Centre- Versus Home-based Exercise for MCI and Early Dementia NCT02774720 Centre-based exercise; Home-based exercise Runs in: Canada · 2 sites |
NA other |
COMPLETED | 44 | University of Waterloo OTHER |
2019-05-29 |
|
Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production NCT03551769 tricaprilin; standard meal; high-fat meal; overnight fast Runs in: Australia · 1 site |
PHASE1 other |
COMPLETED | 20 | Cerecin INDUSTRY |
2019-05-29 |
|
Promoting Activity, Independence and Stability in Early Dementia NCT02874300 High intensity supervision arm; Moderate intensity supervision arm |
NA other |
COMPLETED | 60 | Nottingham University Hospitals NHS Trust OTHER |
2019-05-22 |
|
Acupuncture Prevents Chemobrain in Breast Cancer Patients NCT02457039 Dense cranial electroacupuncture stimulation; Body acupuncture; Lea... Runs in: China; Hong Kong · 6 sites |
NA other |
COMPLETED | 93 | The University of Hong Kong OTHER |
2019-05-20 |
|
Effectiveness of Computerized Cognitive Training in the Elderly With Cognitive Impairment NCT02480738 Computerized Cognitive Training Apparatus |
NA other |
COMPLETED | 26 | Seoul National University Bundang Hospital OTHER |
2019-05-20 |
|
MAD Phase I Study to Investigate Contraloid Acetate NCT03955380 Contraloid Runs in: Germany · 1 site |
PHASE1 other |
COMPLETED | 24 | Prof. Dr. Dieter Willbold OTHER |
2019-05-20 |
|
Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) NCT01953601 Verubecestat 12 mg (Parts 1 and 2); Verubecestat 40 mg (Parts 1 and... |
PHASE3 BACE-inhibitor |
TERMINATED | 1,454 | Merck Sharp & Dohme LLC INDUSTRY |
2019-05-17 |
|
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo NCT02902822 Screening; Tele-dermatology Runs in: Italy · 1 site |
NA other |
COMPLETED | 461 | Centro Studi Gised OTHER |
2019-05-17 |
|
Extension Connection Evaluation NCT02455310 Educational activities to improve dementia care Runs in: United States · 1 site |
NA other |
COMPLETED | 44,524 | Ryan M. Carnahan OTHER |
2019-05-14 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial